Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

106.61
-4.2700-3.85%
Volume:542.16K
Turnover:58.12M
Market Cap:25.59B
PE:-63.25
High:110.88
Open:110.88
Low:105.64
Close:110.88
52wk High:131.49
52wk Low:81.20
Shares:240.00M
Float Shares:93.81M
Volume Ratio:2.67
T/O Rate:0.58%
Dividend:0.00
Dividend Rate:0.00%
EPS(TTM):-1.6856
EPS(LYR):-2.8652
ROE:-1.84%
ROA:-2.14%
PB:1.18
PE(LYR):-37.21

Loading ...

Co-Diagnostics Sales Plunge 93 Percent

Motley Fool
·
Aug 15

BioNTech’s Promising Lung Cancer Study: A Potential Game-Changer for Investors

TIPRANKS
·
Aug 15

BioNTech Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 14

BioNTech Se : H.c. Wainwright Cuts Target Price to $136 From $138

THOMSON REUTERS
·
Aug 14

Vaxart Revenue Jumps 520% in Fiscal Q2

Motley Fool
·
Aug 14

Warburg Research Keeps Their Hold Rating on CANCOM SE (0O0F)

TIPRANKS
·
Aug 13

Warburg Research Keeps Their Buy Rating on Deutsche Beteiligungs (0QF7)

TIPRANKS
·
Aug 13

Firebrick Pharma’s Nasodine COVID-19 Patent Accepted in Europe

TIPRANKS
·
Aug 13

CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency

Benzinga
·
Aug 13

BioNTech’s Promising Trial: BNT113 and Pembrolizumab in Head and Neck Cancer

TIPRANKS
·
Aug 13

Optimistic Buy Rating for Arcturus Therapeutics Driven by Promising Developments in Cystic Fibrosis and COVID-19 Vaccine Programs

TIPRANKS
·
Aug 12

UmweltBank AG (UBK) Receives a Buy from Warburg Research

TIPRANKS
·
Aug 12

FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply

Benzinga_recent_news
·
Aug 12

BioNTech, Pfizer, and CureVac Settle COVID-19 Vaccine Patent Dispute in the U.S., Establish Global Framework

Reuters
·
Aug 11

Meet the 7.3% Yield Dividend Stock That Could Soar in 2026

Motley Fool
·
Aug 10

Top Midday Stories: Trade Desk CEO Says Tariffs Impacting Key Clients; UK Regulator Approves Boeing's Acquisition of Spirit AeroSystems

MT Newswires Live
·
Aug 08

The BioNTech SE (NASDAQ:BNTX) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.
·
Aug 08

CureVac Resolves Patent Litigation with Pfizer/BioNTech, Receives $740 Million Settlement

Reuters
·
Aug 08

BioNTech’s Promising Phase II Study on BNT327 for Small-cell Lung Cancer

TIPRANKS
·
Aug 08

Genmab and BioNTech’s GEN1042 Study: A Potential Game-Changer in Cancer Treatment

TIPRANKS
·
Aug 08